Open original FDA record ↗Recall record
- FDA identifier
- Z-1811-2018
- Company in FDA record
- Tosoh Bioscience Inc
- FDA record creation date
- May 14, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.
Source facts
- Action
- On March 5, 2018, the firm notified all customers who have received product since 2011 of the discontinuation of this product from the market. Customers were instructed to immediately discontinue use of all lot numbers of recalled test and components, remove all recalled materials from inventory, and destroy per the customer's local procedures. Customers were also instructed to notify and forward the information to physicians who have received test results provided by recalled products over the past 6 months to determine if follow up testing is required. Customers were advised that the recalling firm is permanently removing all ST AIA-PACK HbA1c test and components from the market, and were instructed to identify an alternative test option for HbA1c. Customers were asked to complete and return the Recall Acknowledgement Form to the recalling firm. Customers may contact Tosoh Technical Support at 1(800)-248-6764, 8AM-5PM PST (voice mail after hours), seven days a week.
- Initiated
- 2018-03-05
- Root cause
- Nonconforming Material/Component
- Terminated
- 2020-06-16
- Distribution
- USA (nationwide) Distribution including PR and to the states of : AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.
- Recall number
- Z-1811-2018
- Recall status
- Terminated
- CDRH record ID
- 163123
- FDA record created
- 2018-05-14
- Recall event number
- 79708